Knee / Osteoarthritis / Injectable Hydrogels / VAS+KOOS JR

This Circle helps physicians capture and monetize real-world data from their everyday delivery of Injectable Hydrogels for Knee Osteoarthritis.

The Hydrogel Market was valued at $23.4 Billion in 2023, and is estimated to grow to $45.7 Billion by 2033. Knee Osteoarthritis affects approximately 10% of men and 18% of women aged 60 and older globally. In individuals over 65, the prevalence may rise to as high as 40-50%. With global life expectancy increasing, manufacturers will increase spending to obtain regulatory approvals for marketing hydrogel products. Increasingly, that spend will be focused on licensing real-world safety and efficacy data from their everyday customers.

This Circle helps physicians obtain and aggregate those high quality real-world data those companies are looking for. Participation is minimally burdensome, and members will receive recurring license fees once obtained and in accordance with their contribution of Knee Osteoarthritis cases, outcomes and other case data.